Wire
UBS Adjusts Price Target on Amgen to $400 From $390, Maintains Buy Rating
Amgen (AMGN) has an average rating of overweight and mean price target of $357.48, according to analysts polled by FactSet.Price: $350.13, Change: $-0.88, Percent Change: -0.25%
$AMGN